According to Stratview Research’s latest report, titled “European In Vitro Diagnostics Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2022-2028”, the European In Vitro Diagnostics Market is segmented by Product Type (Instruments, Reagents, Software, and Services), by Technique Type (Immunology, Hematology, Clinical Chemistry, Molecular Diagnostics, Coagulation, Microbiology, and Others), by Application Type (Infectious Diseases, Diabetes, Oncology/Cancer, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing, and Others), by End-User Type (Hospitals, Laboratory, Home Care, and Others), and by Country (Germany, France, The UK, Russia, Spain, and Rest of Europe). This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the European In Vitro Diagnostics Market.

Market Insights

According to analysts, the European in vitro diagnostics market was estimated at USD 14.5 billion in 2021 and is likely to grow at a CAGR of 5.15% during 2022-2028 to reach USD 20.66 billion in 2028.

What are in vitro diagnostics?

In vitro diagnostics (IVD) tests are done on samples such as blood or tissue that have been taken from the human body. These tests are used to detect diseases and infections and to monitor the health of a person to treat and prevent diseases. In vitro simply means ‘in glass, thus these tests are performed in test tubes and similar equipment.

Market Dynamics

Major factors driving the European in vitro diagnostics market growth are-

  • An increase in the number of genetic disorders, 
  • An increase in the number of incidences of chronic and infectious diseases,
  • Growing awareness for the early diagnosis of life-threatening diseases,
  • Increasing demand for point-of-care testing

Furthermore, technological advancements in the field of in vitro diagnostic technologies are expected to drive the growth of the market during the forecast period.

Research Methodology

This strategic assessment report, from Stratview Research, provides a comprehensive analysis that reflects today’s European In Vitro Diagnostics Market realities and future market possibilities for the forecast period of 2022 to 2028. The report segments and analyses the market in the most detailed manner in order to provide a panoramic view of the market. The vital data provided in the report can play a vital role in assisting market participants and investors in identifying low-hanging fruits available in the market as well as developing growth strategies to accelerate their growth process.

Segments Analysis

Based on the product type, the market is segmented as instruments, reagents, software, and services. The reagents segment is expected to hold the major share of the market during the forecast period owing to its high precision and accuracy in diagnosis. Furthermore, the Covid-19 pandemic has increased the demand for reagents. Also, an increase in the use of self-diagnosis tests and the number of R&D activities is expected to drive market growth during the forecast period.

Based on the technique type, the market is segmented as immunology, hematology, clinical chemistry, molecular diagnostics, coagulation, microbiology, and others. The molecular diagnostics segment is anticipated to register high growth in the market owing to the increasing demand for molecular diagnosis in infectious diseases. Furthermore, the rapid rise in chronic diseases, as well as the increase in the number of genetic disorders, is expected to drive market growth during the forecast period.

Based on the application type, the market is segmented as infectious diseases, diabetes, oncology/cancer, cardiology, nephrology, autoimmune diseases, drug testing, and others. The infectious diseases application type segment is estimated to account for the major share of the market during the forecast period on account of the increasing number of infectious diseases such as HIV-AIDS, hepatitis, and Respiratory Syncytial Virus. 

In terms of country, Germany is estimated to be the leading country in the market over the forecast period. The growth of the market is owing to the increasing prevalence of infectious diseases and the growing demand for rapid tests. Furthermore, the presence of various manufacturing companies is expected to fuel market growth over the forecast period. The UK is also expected to offer substantial growth opportunities during the forecast period.

The list of Key Players in the report are -

The market for European In Vitro Diagnostics is gradually consolidating with major companies that are performing mergers & acquisitions to quickly gain the leading position and to tap the growing opportunities in this briskly expanding market. Some of the major key players in the European In Vitro Diagnostics Market are listed below.

  • Abbott Laboratories, Inc.,
  • Alere, Inc.,
  • Bio-Rad Laboratories, Inc.,
  • Cepheid, Inc.,
  • Hologic, Inc.,
  • OraSure Technologies,
  • Qiagen N.V.,
  • Quidel Corporation,
  • Roche Diagnostics,
  • Siemens Healthcare GmbH.

About Stratview Research – 

Stratview Research is a leading market research firm that offers wide range of services like syndicated market reports, consulting, sourcing intelligence, and customer research, etc. Stratview Research’s offerings include comprehensive market intelligence in the form of research reports, and consulting services. Our team which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 500 companies.